Caris Life Sciences
CAI
Caris Life Sciences (CAI) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.00
- EPS estimate
- $0.01
- EPS surprise
- −100.00%
- Revenue surprise
- +10.75%
- Revenue
- $263.7M
- Revenue estimate
- $238.1M
- Reported
- Aug 5, 2026
Earnings history
Quarterly revenue
Frequently asked questions
When did Caris Life Sciences (CAI) last report earnings?
Caris Life Sciences last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did CAI beat earnings estimates?
No. Caris Life Sciences reported EPS of $0.00 for Q2 2026 against a $0.01 estimate — a 100.00% miss.
How much revenue did CAI report last quarter?
Caris Life Sciences reported $263.7M in revenue for Q2 2026, against a consensus estimate of $238.1M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.